NeurAxis's PENFS technology is recommended for treating pediatric Functional Abdominal Pain in newly published guidelines, enhancing insurance coverage potential. NeurAxis, Inc. has announced that ...

Practice guidelines published in the Journal of Pediatric Gastroenterology & Nutrition (JPGN) name Percutaneous Electrical Nerve Field Stimulation (PENFS) as a recommended treatment option for FAP ...

IB-Stim is the only pediatric treatment option that the FDA has cleared for FAP in IBS and abdominal pain in functional dyspepsia (to include nausea symptoms) for patients 8-21 years old.

Although most children with functional gastrointestinal disorders, such as FAP and IBS, will improve with time and reassurance, a subset of patients may present to the primary care physician or ...

Management of Functional Abdominal Pain and Irritable Bowel Syndrome in Children and Adolescents Eric Chiou; Samuel Nurko Disclosures Expert Rev Gastroenterol Hepatol. 2010;4 (3):293-304. 0 ...

My colleagues and I, along with other researchers, have developed and tested cognitive behavioural approaches for children with chronic painful conditions such as functional abdominal pain and ...

My colleagues and I, along with other researchers, have developed and tested cognitive behavioural approaches for children with chronic painful conditions such as functional abdominal pain and ...

NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in ...

MSFT, NVDA and BAC shine in Zacks' top picks, with AI, cloud, and higher rates driving strong growth projections.

People often imagine childhood as a time when the body functions at its best, but about 25% of children experience chronic pain. I was one of them: Starting in elementary school, migraines ...